Aurora Cannabis (ACB) Competitors

$3.30 -0.05 (-1.34%)

As of 02:59 PM Eastern

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Aurora Cannabis compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Aurora Cannabis has a net margin of -23.46% compared to Canopy Growth's net margin of -94.39%. Aurora Cannabis' return on equity of -0.04% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-94.39%	-46.85%	-28.95%
Aurora Cannabis	-23.46%	-0.04%	-0.03%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$225.65M	1.85	-$429.86M	-$1.30	N/A
Aurora Cannabis	$246.72M	0.79	$1.63M	-$1.08	N/A

Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

In the previous week, Canopy Growth had 4 more articles in the media than Aurora Cannabis. MarketBeat recorded 8 mentions for Canopy Growth and 4 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.79 beat Aurora Cannabis' score of 0.72 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	2 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Canopy Growth and Aurora Cannabis tied by winning 7 of the 14 factors compared between the two stocks.

How does Aurora Cannabis compare to Cronos Group?

Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 12.75%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Aurora Cannabis has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Aurora Cannabis has higher revenue and earnings than Cronos Group. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$246.72M	0.79	$1.63M	-$1.08	N/A
Cronos Group	$146.59M	6.77	-$9.45M	$0.01	263.60

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
Cronos Group	-1.14%	-1.26%	-1.20%

In the previous week, Cronos Group had 11 more articles in the media than Aurora Cannabis. MarketBeat recorded 15 mentions for Cronos Group and 4 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 0.85 beat Aurora Cannabis' score of 0.72 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cronos Group beats Aurora Cannabis on 11 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Aurora Cannabis has higher revenue and earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A
Aurora Cannabis	$246.72M	0.79	$1.63M	-$1.08	N/A

Organigram Global has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Aurora Cannabis	-23.46%	-0.04%	-0.03%

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Organigram Global had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for Organigram Global and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.72 beat Organigram Global's score of 0.18 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Organigram Global beats Aurora Cannabis on 8 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to SNDL?

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

SNDL has a consensus target price of $5.00, suggesting a potential upside of 250.88%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SNDL	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Aurora Cannabis has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, SNDL has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

In the previous week, Aurora Cannabis had 3 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 1.89 beat Aurora Cannabis' score of 0.72 indicating that SNDL is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Positive
SNDL	Very Positive

Aurora Cannabis has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$246.72M	0.79	$1.63M	-$1.08	N/A
SNDL	$937.39M	0.39	-$11.29M	-$0.03	N/A

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
SNDL	-1.19%	-1.02%	-0.85%

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Aurora Cannabis beats SNDL on 9 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$246.72M	0.79	$1.63M	-$1.08	N/A
Tilray Brands	$821.31M	0.75	-$2.19B	-$13.65	N/A

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 0.8% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Tilray Brands has a consensus price target of $11.50, indicating a potential upside of 116.78%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Tilray Brands had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 14 mentions for Tilray Brands and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.72 beat Tilray Brands' score of 0.70 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	6 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a net margin of -23.46% compared to Tilray Brands' net margin of -156.51%. Aurora Cannabis' return on equity of -0.04% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
Tilray Brands	-156.51%	-3.31%	-2.42%

Aurora Cannabis has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market.

Summary

Aurora Cannabis and Tilray Brands tied by winning 8 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$195.36M	$7.96B	$6.23B	$12.35B
Dividend Yield	N/A	2.53%	2.80%	5.35%
P/E Ratio	-3.06	15.86	20.41	25.39
Price / Sales	0.79	8.09	541.58	73.15
Price / Cash	5.46	16.82	43.26	56.33
Price / Book	0.42	3.57	9.83	6.93
Net Income	$1.63M	$223.05M	$3.56B	$333.88M
7 Day Performance	-3.08%	-2.72%	0.52%	0.03%
1 Month Performance	-10.19%	-0.72%	-0.71%	1.93%
1 Year Performance	-33.37%	-0.07%	36.34%	33.14%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	1.0898 of 5 stars	$3.31 -1.3%	N/A	-33.5%	$195.36M	$246.72M	N/A	1,130
CGC Canopy Growth	2.0709 of 5 stars	$1.10 -2.7%	N/A	-24.1%	$456.66M	$225.65M	N/A	3,150
CRON Cronos Group	1.6691 of 5 stars	$2.65 +0.4%	$2.30 -13.2%	+33.0%	$993.36M	$146.59M	N/A	450	Earnings Report Analyst Forecast
OGI Organigram Global	1.0349 of 5 stars	$1.39 -2.1%	N/A	-10.7%	$199.89M	$185.07M	9.93	1,139	Earnings Report
SNDL SNDL	3.725 of 5 stars	$1.42 +0.7%	$5.00 +252.1%	+14.1%	$362.93M	$677.32M	N/A	2,751	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACB) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Summary

How does Aurora Cannabis compare to Cronos Group?

Summary

How does Aurora Cannabis compare to Organigram Global?

Summary

How does Aurora Cannabis compare to SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Is CGC or ACB more profitable?

Which has preferable earnings and valuation, CGC or ACB?

Which has more risk and volatility, CGC or ACB?

Does the media refer more to CGC or ACB?

Do institutionals & insiders hold more shares of CGC or ACB?

Do analysts prefer CGC or ACB?

Summary

How does Aurora Cannabis compare to Cronos Group?

Do analysts rate ACB or CRON?

Which has more volatility and risk, ACB or CRON?

Do institutionals & insiders believe in ACB or CRON?

Which has stronger earnings and valuation, ACB or CRON?

Is ACB or CRON more profitable?

Does the media refer more to ACB or CRON?

Summary

How does Aurora Cannabis compare to Organigram Global?

Which has stronger valuation and earnings, OGI or ACB?

Which has more risk & volatility, OGI or ACB?

Is OGI or ACB more profitable?

Do institutionals & insiders have more ownership in OGI or ACB?

Does the media prefer OGI or ACB?

Do analysts rate OGI or ACB?

Summary

How does Aurora Cannabis compare to SNDL?

Do analysts prefer ACB or SNDL?

Which has more risk & volatility, ACB or SNDL?

Does the media refer more to ACB or SNDL?

Which has better earnings & valuation, ACB or SNDL?

Is ACB or SNDL more profitable?

Do institutionals & insiders hold more shares of ACB or SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Which has preferable earnings and valuation, ACB or TLRY?

Do insiders and institutionals believe in ACB or TLRY?

Do analysts rate ACB or TLRY?

Does the media favor ACB or TLRY?

Is ACB or TLRY more profitable?

Which has more risk and volatility, ACB or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools